Literature DB >> 9689798

Chronic respiratory failure in a patient with type I Arnold-Chiari malformation (ACM1) and syringomyelia.

F Fanfulla1, D Eleftheriou, V Patruno, C Bruschi, C Rampulla.   

Abstract

We present the case of a young adult with type I Arnold-Chiari malformation (AMC1) and syringomyelia who developed central sleep apnoea and chronic respiratory failure, successfully treated with nocturnal noninvasive positive pressure ventilation ventilation (NIPPV). An extensive syringomyelic cavity (from bulbar to L4 segment) with severe impairment of the IX cranial nerve was documented and remains, although reduced, after the neurosurgical treatment. At baseline evaluation, the patient showed a moderate restrictive ventilatory defect, severe hypercapnic respiratory failure, abnormal control of breathing characterized by the absence of response to hypoxia and hypercapnia, and severe nocturnal central apnoeas. Nocturnal NIPPV was then started in the A/C mode with an improvement in blood gas values. Further evaluations were performed 10 and 18 months later. A progressive significant improvement of lung volumes, both in sitting and supine position, associated with a slight improvement of blood-gas values were observed. Nonetheless, the breathing pattern abnormalities persisted. Polysomnographic evaluation during mechanical ventilation showed a normalization of breathing pattern with arterial oxygen saturation (SaO2) > 90% throughout the night.

Entities:  

Mesh:

Year:  1998        PMID: 9689798

Source DB:  PubMed          Journal:  Monaldi Arch Chest Dis        ISSN: 1122-0643


  2 in total

1.  Hindbrain-hernia-related syringomyelia without syringobulbia, complicated by permanent nocturnal central hypoventilation requiring non-invasive ventilation.

Authors:  Ranjeev Bhangoo; Spyros Sgouros; A Richard Walsh; Jane R Clarke
Journal:  Childs Nerv Syst       Date:  2005-09-24       Impact factor: 1.475

Review 2.  Adult Chiari malformation and sleep apnoea.

Authors:  Ricardo Vieira Botelho; Lia Rita Azeredo Bittencourt; José Marcus Rotta; Sérgio Tufik
Journal:  Neurosurg Rev       Date:  2005-05-21       Impact factor: 3.042

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.